Beta Bionics, Inc. (BBNX) Other Non-Current Liabilities (2023 - 2026)

Beta Bionics (BBNX) posted Other Non-Current Liabilities of $1.6 million for Q1 2026, up 0.71% sequentially from $1.5 million in Q4 2025, and up 289.5% YoY from $400000.0 in Q1 2025.

Beta Bionics, Inc. (BBNX) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends

Beta Bionics (BBNX) has 4 years of Other Non-Current Liabilities data on file, last reported at $1.6 million in Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 289.5% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 289.5% YoY) and the FY2025 annual result came in at $1.5 million, down 96.55% from the prior year.
  • Other Non-Current Liabilities improved to $1.6 million in Q1 2026 per BBNX's latest filing, from $1.5 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $44.9 million in Q4 2024, with the low at $400000.0 in Q1 2025.
  • Average Other Non-Current Liabilities over 4 years is $10.4 million, with a median of $1.5 million recorded in 2025.
  • Year-over-year, Other Non-Current Liabilities tumbled 96.55% in 2025 and jumped 289.5% in 2026.
  • Beta Bionics' Other Non-Current Liabilities stood at $22.3 million in 2023, then surged by 101.15% to $44.9 million in 2024, then slumped by 96.55% to $1.5 million in 2025, then increased by 0.71% to $1.6 million in 2026.
  • Business Quant data shows BBNX's Other Non-Current Liabilities at $1.6 million in Q1 2026, $1.5 million in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2026 1.56 Mn
Dec 31, 2025 1.55 Mn
Sep 30, 2025 1.21 Mn
Jun 30, 2025 1.01 Mn
Mar 31, 2025 400,000.00
Dec 31, 2024 44.90 Mn
Dec 31, 2023 22.32 Mn